Screening compound: RMRXTYKQFSVLDO-UHFFFAOYSA-N

Screening compound: RMRXTYKQFSVLDO-UHFFFAOYSA-N
Screening compound: RMRXTYKQFSVLDO-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
RMRXTYKQFSVLDO-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E218-0694

Molecular Formula

C27H40N4O3 (C27 H40 N4 O3)

Compound Name

7-{2-[cyclohexyl(methyl)amino]ethyl}-6-methyl-N~6~-(2-methylcyclohexyl)-8-oxo-5,6,7,8-tetrahydrofuro[2',3':4,5]pyrrolo[1,2-a]pyrazine-6-carboxamide

IUPAC name

10-{2-[cyclohexyl(methyl)amino]ethyl}-11-methyl-N-(2-methylcyclohexyl)-9-oxo-5-oxa-110-diazatricyclo[6.4.0.0^{26}]dodeca-2(6)37-triene-11-carboxamide

SMILES

CC(CCCC1)C1NC(C(C)(Cn1c2cc3c1cco3)N(CCN(C)C1CCCCC1)C2=O)=O

InChI

InChI=1S/C27H40N4O3/c1-19-9-7-8-12-21(19)28-26(33)27(2)18-30-22-13-16-34-24(22)17-23(30)25(32)31(27)15-14-29(3)20-10-5-4-6-11-20/h13,16-17,19-21H,4-12,14-15,18H2,1-3H3,(H,28,33)

InChI Key

RMRXTYKQFSVLDO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27597955

RMRXTYKQFSVLDO-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antimitotic Tubulin Library (17355 compounds)

Antiviral Library (67538 compounds)

Cyclic Ugi PPI Library (9586 compounds)

GABA Library (7115 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Akt-Targeted Library (14764 compounds)

Anti-HIV1 Library (19540 compounds)

Developmental Pathway (Hh/Wnt) Set (2238 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Eye
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Female
  • Hemic and lymphatic
  • Skin
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • Epigenetic
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics
Targets:
  • GPCR
  • Ion Channels
  • Others
  • Kinases
  • Others

References: we are preparing a list of scientific research reports with RMRXTYKQFSVLDO-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound RMRXTYKQFSVLDO-UHFFFAOYSA-N?
Check Price and Availability of RMRXTYKQFSVLDO-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of RMRXTYKQFSVLDO-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for RMRXTYKQFSVLDO-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for RMRXTYKQFSVLDO-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of RMRXTYKQFSVLDO-UHFFFAOYSA-N available by request